CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

被引:634
作者
Ginestier, Christophe [1 ,2 ]
Liu, Suling [1 ]
Diebel, Mark E. [1 ]
Korkaya, Hasan [1 ]
Luo, Ming [3 ]
Brown, Marty [1 ]
Wicinski, Julien [2 ]
Cabaud, Olivier [2 ]
Charafe-Jauffret, Emmanuelle [2 ]
Birnbaum, Daniel [2 ]
Guan, Jun-Lin [3 ]
Dontu, Gabriela [1 ]
Wicha, Max S. [1 ]
机构
[1] Univ Michigan, Dept Internal Med Oncol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[2] Univ Mediterranee, UMR891, INSERM,Lab Oncol Mol, Inst J Paoli I Calmettes,Ctr Recherche & Cancerol, FR-13009 Marseille, France
[3] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet & Cell & Dev Biol, Ann Arbor, MI USA
关键词
CHEMOKINE RECEPTORS; GENE-EXPRESSION; TUMOR-GROWTH; FAS LIGAND; KINASE; PATHWAY; DEATH; TUMORIGENICITY; PROPAGATION; RESISTANCE;
D O I
10.1172/JCI39397
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Recent evidence suggests that breast cancer and other solid tumors possess a rare population of cells capable of extensive self-renewal that contribute to metastasis and treatment resistance. We report here the development of a strategy to target these breast cancer stem cells (CSCs) through blockade of the IL-8 receptor CXCR1. CXCR1 blockade using either a CXCR1-specific blocking antibody or repertaxin, a small-molecule CXCR1 inhibitor, selectively depleted the CSC population in 2 human breast cancer cell lines in vitro. Furthermore, this was followed by the induction of massive apoptosis in the bulk tumor population via FASL/FAS signaling. The effects of CXCR1 blockade on CSC viability and on FASL production were mediated by the FAK/AKT/FOXO3A pathway. In addition, repertaxin was able to specifically target the CSC population in human breast cancer xenografts, retarding tumor growth and reducing metastasis. Our data therefore suggest that CXCR1 blockade may provide a novel means of targeting and eliminating breast CSCs.
引用
收藏
页码:485 / 497
页数:13
相关论文
共 39 条
[1]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]   The MHP36 line of murine neural stem cells expresses functional CXCR1 chemokine receptors that initiate chemotaxis in vitro [J].
Beech, John Samuel ;
Wheeler, Daniel Wren ;
Reckless, Jill ;
Grant, Andrew James ;
Price, Jack ;
Mastroeni, Pietro ;
Grainger, David John ;
Menon, David Krishna .
JOURNAL OF NEUROIMMUNOLOGY, 2007, 184 (1-2) :198-208
[3]   Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury [J].
Bertini, R ;
Allegretti, M ;
Bizzarri, C ;
Moriconi, A ;
Locati, M ;
Zampella, G ;
Cervellera, MN ;
Di Cioccio, V ;
Cesta, MC ;
Galliera, E ;
Martinez, FO ;
Di Bitondo, R ;
Troiani, G ;
Sabbatini, V ;
D'Anniballe, G ;
Anacardio, R ;
Cutrin, JC ;
Cavalieri, B ;
Mainiero, F ;
Strippoli, R ;
Villa, P ;
Di Girolamo, M ;
Martin, F ;
Gentile, M ;
Santoni, A ;
Corda, D ;
Poli, G ;
Mantovani, A ;
Ghezzi, P ;
Colotta, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) :11791-11796
[4]   Stem cells and the stem cell niche in the breast: An integrated hormonal and developmental perspective [J].
Brisken, Cathrin ;
Duss, Stephan .
STEM CELL REVIEWS, 2007, 3 (02) :147-156
[5]   Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a) [J].
Brunet, A ;
Park, J ;
Tran, H ;
Hu, LS ;
Hemmings, BA ;
Greenberg, ME .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (03) :952-965
[6]   Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature [J].
Charafe-Jauffret, Emmanuelle ;
Ginestier, Christophe ;
Iovino, Flora ;
Wicinski, Julien ;
Cervera, Nathalie ;
Finetti, Pascal ;
Hur, Min-Hee ;
Diebel, Mark E. ;
Monville, Florence ;
Dutcher, Julie ;
Brown, Marty ;
Viens, Patrice ;
Xerri, Luc ;
Bertucci, Francois ;
Stassi, Giorgio ;
Dontu, Gabriela ;
Birnbaum, Daniel ;
Wicha, Max S. .
CANCER RESEARCH, 2009, 69 (04) :1302-1313
[7]   Bystander killing of breast cancer MCF-7 cells by MDA-MB-231 cells exposed to 5-fluorouracil is mediated via Fas [J].
Chhipa, Rishi Raj ;
Bhat, Manoj Kumar .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 101 (01) :68-79
[8]   Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features [J].
Creighton, Chad J. ;
Li, Xiaoxian ;
Landis, Melissa ;
Dixon, J. Michael ;
Neumeister, Veronique M. ;
Sjolund, Ashley ;
Rimm, David L. ;
Wong, Helen ;
Rodriguez, Angel ;
Herschkowitz, Jason I. ;
Fan, Cheng ;
Zhang, Xiaomei ;
He, Xiaping ;
Pavlick, Anne ;
Gutierrez, M. Carolina ;
Renshaw, Lorna ;
Larionov, Alexey A. ;
Faratian, Dana ;
Hilsenbeck, Susan G. ;
Perou, Charles M. ;
Lewis, Michael T. ;
Rosen, Jeffrey M. ;
Chang, Jenny C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (33) :13820-13825
[9]   High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability [J].
Croker, Alysha K. ;
Goodale, David ;
Chu, Jenny ;
Postenka, Carl ;
Hedley, Benjamin D. ;
Hess, David A. ;
Allan, Alison L. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (8B) :2236-2252
[10]   In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells [J].
Dontu, G ;
Abdallah, WM ;
Foley, JM ;
Jackson, KW ;
Clarke, MF ;
Kawamura, MJ ;
Wicha, MS .
GENES & DEVELOPMENT, 2003, 17 (10) :1253-1270